All Stories

  1. Exploring the mechanistic interplay between chronic high sugar consumption, gut microbiota, and Alzheimer's disease: Implications for drug discovery
  2. Vitamin B12 Deficiency in Sickle Cell Disease: Method‐Driven Estimates and Systematic Diagnostic Misclassification
  3. Care Delivery Gap framework: a proof-of-concept patient-reported measure of guideline-referenced care-process omissions in sickle cell disease
  4. Vitamin B12 Assessment in Sickle Cell Disease: A Systematic Evaluation of Diagnostic Validity and Misclassification
  5. Probiotics: An Emerging Tool against Pathogenic Bacteria
  6. Harnessing Viruses Against Multidrug‐Resistant Bacteria: Exploring the Potential of Bacteriophage‐Based Drug Discovery
  7. Phyto-molecules show potentials to combat drug-resistance in bacterial cell membranes
  8. Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
  9. Omega-3 in traditional medicine and its role in the treatment of Sickle Cell Disease complications
  10. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies
  11. Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications
  12. Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review
  13. Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature
  14. Immunomodulatory Benefits of Probiotic Bacteria: A Review of Evidence
  15. Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders—Global public health consequences
  16. Lactic acid bacteria fermented foods: Impact on immune system and consequences over type 2 diabetes mellitus
  17. The Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Can Combat Cytokine Storm and Other COVID-19 Related Pathologies: A Review
  18. In silico identification of the potential natural inhibitors of SARS-CoV-2 Guanine-N7 methyltransferase
  19. Challenges and Implications of the COVID-19 Pandemic on Mental Health: A Systematic Review
  20. The Antioxidant and Hematopoietic Effects of the Methanolic Extract Fractions of Ocimum basilicum in Acetaminophen-Induced Albino Rats
  21. RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION
  22. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
  23. Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach
  24. Utilization of physical and chemical microbial load reduction agents for SARS-CoV-2: Toxicity and development of drug resistance implications
  25. Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
  26. An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia
  27. Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach
  28. In silico screening and molecular dynamic simulation studies of potential small molecule immuno-modulators of the KIR2DS2 receptor
  29. The ameliorative effect of the solvent extracts of Ocimum basilicum against acetaminophen-induced liver damage in albino rats
  30. Camptothecin shows better promise than Curcumin in the inhibition of the Human Telomerase: A computational study
  31. Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review
  32. Effect of oral administration of Pleuroteus tuber-regium extract on growth, serum metabolites and histomorphological changes in growing rabbits
  33. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
  34. In Silico Identification of Potential Allosteric Inhibitors of the SARS-CoV-2 Helicase
  35. The Structure-Based Virtual Screening for Natural Compounds that Bind with the Activating Receptors of Natural Killer Cells
  36. In vivo Effects of Aqueous Extract of Gongronema latifolium Benth on the Tumor Necrosis Factor-α, Transforming Growth Factor-β, and Hepatic Enzymes
  37. Effect of Oral Administration of Pleuroteus Tuber-Regium Extract on Growth, Serum Metabolites and Histomorphological Changes in Growing Rabbits
  38. The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
  39. In Silico Identification of the Potential Natural Inhibitors of SARS-CoV-2 Guanine-N7 Methyltransferase.
  40. In Silico Identification of Potential Allosteric Inhibitors of the SARS-CoV-2 Helicase
  41. In Silico Identification of Potential Allosteric Inhibitors of the SARS-CoV-2 Helicase
  42. In Silico Identification of Potential Allosteric Inhibitors of the SARS-CoV-2 Helicase
  43. The Structure-Based Virtual Screening for Natural Compounds that Bind with the Activating Receptors of Natural Killer Cells
  44. IN SILICOSCREENING AND MOLECULAR DYNAMIC SIMULATION STUDIES OF POTENTIAL SMALL MOLECULE IMMUNOMODULATORS OF THE KIR2DS2 RECEPTOR
  45. Investigating the ameliorative effects of the aqueous extract of Pleurotus ostreatus on cyclophosphamide-induced cytotoxicity in rabbits
  46. The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction